never thought i'd see anyone more conservative than me. the share count makes it tougher these days, but i still expect a spike in the price above the .54 level and perhaps pushing to $1.00 or even $1.30 with good data beyond just biomarkers. plenty of PRs coming in the next 6 months.
11